Antiviral drugs : from basic discovery through clinical trials /

Antiviral drugs : from basic discovery through clinical trials /

Includes bibliographical references and index

Bibliographic Details
Main Author:	Kazmierski, Wieslaw M.
Format:
Language:	eng
Published:	Hoboken, N.J. : Wiley, c201
Subjects:	Antiviral agents Antiviral Agents Clinical Trials as Topic Drug Discovery

Similar Items

Antiviral research : strategies in antiviral drug discovery /
by: LaFemina, Robert L., et al.
Published: (c200)

Antiviral drug discovery for emerging diseases and bioterrorism threats /
by: Torrence, Paul F.
Published: (2005)

Successful strategies for the discovery of antiviral drugs /
by: Desai, Manoj C., et al.
Published: (2013)

Approaches to antiviral agents /
by: Harnden, Michael R.
Published: (1985)

Design of anti-AIDS drugs /
by: De Clercq, Erik, et al.
Published: (1990)

Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide
by: Jackman, Joshua A., et al.
Published: (2020)

Antiviral chemotherapy : design of inhibitors of viral functions /
by: Gauri, K. K., et al.
Published: (1981)

Undeveloped Region in Target-Strategies and Potential in Antiviral Drug Discovery
by: Shaoqing Du, et al.

ROTAVIRAL INFECTION IN CHILDREN: CLINICAL PRESENTATION AND ASSESSMENT OF ANTIVIRAL TREATMENT EFFICACY
by: E. V. Mikhailova, et al.
Published: (2012-11-01)

Life saving drugs : the elusive magic bullet /
by: 217893 Mann, John, et al.
Published: (2004)

New concepts of antiviral therapy / [electronic resource]
by: Holzenburg, Andreas, et al.
Published: (2006)

Cancer-causing viruses and their inhibitors /
by: Gupta, Satya Prakash, editor
Published: (2014)

Advanced therapy for hepatitis C /
by: McCaughan, Geoffrey W., et al.
Published: (2012)

Cloning and overexpression of influenza A H1N1 NS1 protein in Escherichia coli /
by: Ong, Lih Lih, 1983-, et al.
Published: (2010)

Cloning and overexpression of influenza A H1N1 NS1 protein in Escherichia coli [electronic resource] /
by: Ong, Lih Lih, 1983-
Published: (2010)

Design and analysis of clinical trials with time-to-event endpoints /
by: Peace, Karl E., 1941-
Published: (c200)

Risk of hepatocellular carcinoma with tenofovir vs entecavir treatment for chronic hepatitis B virus: a reconstructed individual patient data meta-analysis
by: Tan, Darren Jun Hao, et al.
Published: (2023)

RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS
by: S. V. Zhavoronok, et al.
Published: (2018-10-01)

SOME ASPECTS OF THE MARKETING STUDIES FOR THE PHARMACEUTICAL MARKET OF ANTIVIRAL DRUGS
by: A. G. Salnikova, et al.
Published: (2015-12-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
by: V. V. Poloskov, et al.
Published: (2019-01-01)

Handbook of adaptive designs in pharmaceutical and clinical development /
by: Pong, Annpey, et al.
Published: (2011)

Current Trends in Clinical Trials of Prodrugs
by: Diogo Boreski, et al.
Published: (2025-02-01)

Machine Learning for Drug Discovery /
by: Melo, Marcelo C.R., author 652450, et al.
Published: (2022)

Antiviral treatment for viral pneumonia: current drugs and natural compounds
by: Hao Zhang, et al.
Published: (2025-03-01)

Planning a clinical trial programme for direct-acting antivirals for chronic viral hepatitis C
by: A. I. Gubenko, et al.
Published: (2023-12-01)

Study of the Antiviral Activity of Drugs and Their Combination Against the Influenza A Virus
by: E. N. Vetrova, et al.
Published: (2025-02-01)

Antiviral cystine knot α-amylase inhibitors from alstonia scholaris
by: Nguyen, Phuong Quoc Thuc, et al.
Published: (2018)

Fitokimyasalların Antiviral Etkileri
by: Tuğba Demir, et al.
Published: (2021-07-01)

Antiviral Properties of Basidiomycetes Metabolites
by: A. V. Avtonomova, et al.
Published: (2020-05-01)

Assignment optimization of pandemic influenza antiviral drugs in Urban pharmacies
by: Zhang, Chijun, et al.
Published: (2020)

In Vitro Evaluation of the Antiviral Activity of Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) Against Mayaro Virus
by: Pâmela Jóyce Previdelli da Conceição, et al.
Published: (2025-02-01)

Clinico-laboratory and immunological characteristics of patients with compensated cirrhosis of the liver in the outcome of chronic hepatitis C on the background of treatment with a direct antiviral drug paritrapeprir/ritonavir/ombitasvir/ dasabuvir
by: L. L. Popova, et al.
Published: (2018-12-01)

Statistics applied to clinical trials /
by: 191239 Cleophas, Ton J. M., et al.
Published: (2002)

Statistics applied to clinical trials /
by: 191239 Cleophas, Ton J. M., et al.
Published: (2006)

Outcomes of liver transplantation in the era of modern antiviral therapy for hepatitis C
by: K. Yu. Kokina, et al.
Published: (2021-04-01)

Subacute Sclerosing Panencephalitis: Impact on Public Health, Current Insights, and Future Perspectives
by: Zainab Mubbashir, et al.
Published: (2025-02-01)

Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore
by: Soh, Alexius Matthias Sheng En, et al.
Published: (2024)

Tuberculosis : laboratory diagnosis and treatment strategies /
by: McHugh, Timothy D. (Timothy Daniel)
Published: (c201)

Statistical monitoring of clinical trials : a unified approach /
by: 306564 Proschan, Michael A., et al.
Published: (2006)

Antiviral Activity of Panavir in Experimental Infection Due to Morbillivirus in Cell Cultures
by: S. G. Markushin, et al.
Published: (2020-05-01)